Literature DB >> 24592040

Advanced stage micropapillary serous borderline ovarian tumor in a postmenopausal woman: a case report.

Tayfun Güngör1, Metin Kaba1, Eralp Başer1, Hakan Yalçın1, Hatice Bayramoğlu2, Mustafa Beşli1.   

Abstract

Serous borderline ovarian tumors (SBOT) generally occur in young women, present at early stages and are associated with an excellent prognosis. However, there are rare subtypes of SBOT which may exhibit a more aggressive course. In contrast with other types of SBOT, the micropapillary variant SBOT (SBOT-MP) tends to present at advanced stages. Herein, we present a rare case of a SBOT-MP that occurred in a 66-year-old woman, who had tumoral involvement on bilateral ovaries, sigmoid serosa and a positive peritoneal cytology. The currently recommended treatment options for these cases are also discussed.

Entities:  

Keywords:  Borderline ovarian tumor; advanced stage; micropapillary; peritoneal implant; postmenopause

Year:  2012        PMID: 24592040      PMCID: PMC3939243          DOI: 10.5152/jtgga.2012.30

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  12 in total

1.  Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study.

Authors:  G Zanetta; S Rota; S Chiari; C Bonazzi; G Bratina; C Mangioni
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

2.  Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?

Authors:  Mine Kanat-Pektas; Mustafa Ozat; Tayfun Gungor; Izzet Sahin; Hakan Yalcin; Bulent Ozdal
Journal:  Arch Gynecol Obstet       Date:  2010-06-13       Impact factor: 2.344

3.  Fertility outcome after conservative surgery for borderline ovarian tumors: a single center experience.

Authors:  Mine Kanat-Pektas; Mustafa Ozat; Tayfun Gungor; Türkan Dikici; Bulent Yilmaz; Leyla Mollamahmutoglu
Journal:  Arch Gynecol Obstet       Date:  2010-12-18       Impact factor: 2.344

4.  Surgical staging in patients with ovarian tumors of low malignant potential.

Authors:  William E Winter; Paul R Kucera; William Rodgers; John W McBroom; Cara Olsen; G Larry Maxwell
Journal:  Obstet Gynecol       Date:  2002-10       Impact factor: 7.661

5.  Significance of peritoneal washing cytopathology in ovarian carcinomas and tumors of low malignant potential: a quality control study with literature review.

Authors:  Sevgiye Kaçar Özkara
Journal:  Acta Cytol       Date:  2010-11-26       Impact factor: 2.319

6.  Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.

Authors:  Teri A Longacre; Jesse K McKenney; Henry D Tazelaar; Richard L Kempson; Michael R Hendrickson
Journal:  Am J Surg Pathol       Date:  2005-06       Impact factor: 6.394

7.  Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.

Authors:  Suk-Joon Chang; Hee-Sug Ryu; Ki-Hong Chang; Seung-Chul Yoo; Jong-Hyuck Yoon
Journal:  Acta Obstet Gynecol Scand       Date:  2008       Impact factor: 3.636

8.  Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.

Authors:  Russell Hogg; James Scurry; Soo-Nyung Kim; Michael Friedlander; Neville Hacker
Journal:  Gynecol Oncol       Date:  2007-04-27       Impact factor: 5.482

9.  Behaviour of ovarian tumors of low malignant potential treated with conservative surgery.

Authors:  P De Iaco; A Ferrero; F Rosati; M Melpignano; N Biglia; M Rolla; D De Aloysio; P Sismondi
Journal:  Eur J Surg Oncol       Date:  2008-11-14       Impact factor: 4.424

10.  Low-grade serous carcinoma of the ovary displaying a macropapillary pattern of invasion.

Authors:  Anna Yemelyanova; Tsui-Lien Mao; Naomi Nakayama; Ie Ming Shih; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2008-12       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.